Category: Providers

Biogen Adds Drug with Narrow Approval to 340B Contract Pharmacy Restrictions

December 5, 2023 Rich Daly, Editor in Chief Views

Drugmaker Biogen recently added a third drug to its 340B contract pharmacy restrictions for hospitals.

Biopharmaceutical manufacturer Biogen recently expanded its contract pharmacy restrictions for hospitals to a third drug, after that medication garnered a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Reforms Needed, Says Former Presidential Candidate, Drug Industry Consultant

December 5, 2023 Rich Daly, Editor in Chief Views

Howard Dean, a former Democratic presidential candidate who has consulted for the drug industry, said the 340B program is in need of reforms.

The 340B program has become “a multibillion-dollar boondoggle for hospital mega-chains” and needs reform, says Howard Dean, a one-time Democratic [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

N.Y. State, Health Centers Seek Brief Pause in Medicaid Drug Benefit Lawsuit

November 30, 2023 Tom Mirga, Editor at Large Views

The parties involved in a legal challenge over certain Medicaid managed care drug benefits have jointly asked for a pause in proceedings.

Both sides in a lawsuit over New York state’s transfer of Medicaid managed care drug benefits to Medicaid fee for [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Column: Why the Genesis 340B Patient Definition Court Decision Could Resolve the Contract Pharmacy Impasse

November 30, 2023 Ted Slafsky, Publisher & CEO Views

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.

In what legal experts describe as a landmark decision, the U.S. District Court for the District of South Carolina ruled [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Massachusetts Senate Passes 340B Contract Pharmacy Protections for Certain 340B Grantees, Hospitals

November 28, 2023 William Newton, Associate Editor/Senior Writer Views

Massachusetts lawmakers are expected to vote on Sen. Pavel Payano's (D) 340B PBM nondiscrimination bill Thursday.

Massachusetts state senators this month unanimously passed a healthcare bill that would protect 340B grantees and certain safety net hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provides Benefits, Needs Reform, Says Literature Review

November 28, 2023 Tom Mirga, Editor at Large Views

A JAMA Health Network literature review found that the 340B program provides a range of benefits but needs reforms.

The 340B program has provided a range of benefits but also needs reforms, according to a recent review of published [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B’s Footprint in Medicare Part D Is Growing, Study Says

November 28, 2023 Tom Mirga, Editor at Large Views

A JAMA Health Forum study co- authored by Sean Dickson found the 340B program's footprint in Medicare Part D is increasing.

340B covered entities captured nearly half (49.9%) of their 340B-eligible prescriptions billed to Medicare Part D in 2020, up from [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sen. Cassidy Mum on Next Steps for 340B Provider Probes

November 28, 2023 William Newton, Associate Editor/Senior Writer Views

The drug industry and 340B program advocates offered mixed reactions Monday to a key senator’s latest inquiries into drugmakers’ contract pharmacy restrictions as part of an ongoing congressional probe of the drug pricing program.

The influential senator who launched an inquiry into how two community health centers and two 340B hospitals use 340B savings [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Two Drugmakers Offer Refunds for 340B Overcharges

November 28, 2023 Tom Mirga, Editor at Large Views

Two drugmakers, Mallinckrodt's subsidiary SpecGx and Novo Nordisk, owe refunds to 340B providers for certain overcharges.

Two drugmakers will offer refunds to 340B providers for overcharges in recent years. Drug manufacturer Mallinckrodt’s SpecGx generic pharmaceutical subsidiary [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Michigan Bill Introduced to Protect 340B Contract Pharmacy Arrangements

November 17, 2023 William Newton, Associate Editor/Senior Writer Views

Michigan state Rep. Alabas Farhat (D) introduced a bipartisan bill designed to protect 340B contract pharmacy arrangements in the state.

Michigan state lawmakers this week introduced a bill designed to protect 340B contract pharmacy arrangements from drug manufacturer restrictions. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live